Thu. 28 Mar 2024, 11:35pm ET
Benzinga
Earnings, Earnings Misses, News
SELLAS Life Sciences Gr (NASDAQ:SLS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 41.86 percent increase over losses of $(0.43) per share from the same period last year.